OpenAlex
PricingAboutJobs
Log inGet started
Work

Disease-modifying benefit of Fyn blockade persists after washout in mouse Alzheimer's model

HTML

Year: 2017
Type: article
Source: Neuropharmacology
DOI: 10.1016/j.neuropharm.2017.11.042
Authors: Levi M. Smith, Rong Zhu, Stephen M. Strittmatter
Institution: Yale University
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, saracatinib, disease-modifying therapy, drug washout, memantine, APPswe/PS1ΔE9 mice, spatial memory, synaptic density, transgenic mouse model
SDG: Good health and well-being

Open Access status: green

Funders: Dr. Ralph and Marian Falk Medical Research Trust, National Institutes of Health, National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences
Awards: Characterizing and Targeting Pyk2 Kinase in Alzheimer’s Disease, Genome-Wide Discovery and Translational Research for Neural Repair, Fyn Inhibition by AZD0530 for Alzheimers Disease, Yale Alzheimer Disease Research Center, mGluR5 and Phase State Dependent Synaptic Loss in Alzheimer's Disease
OpenAlex ID: W2768778622
FWCI: 1.868
Cites: 48
Cited by: 54
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security